Huiqing Wang
Biographic Data
| ID | 3975599 |
|---|---|
| NAME | Huiqing Wang |
| GIVEN NAMES | Huiqing |
| FAMILY NAME | Wang |
| SIGNATURE | WANG H |
| AFFILIATIONS | Sichuan University |
| ORCID | 0000-0002-2842-7212 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Walking, the body, and the pandemic
In December 2022, the dynamic zero-COVID control policy came to an end, marking the conclusion of a three-year pandemic that affected 1.4 billion Chinese people. The pandemic and related policies created a unique, temporary, and historic social ecosystem where walking became more crucial than ever before. The pandemic not only severely restricted people's movement in public spaces but also exposed the longstanding contradictions between human bod…
Recombinant mycobacterium tuberculosis fusion protein for diagnosis of mycobacterium tuberculosis infection
Objectives: Recombinant Mycobacterium tuberculosis fusion protein (EC) was anticipated to be used for the scale-up of clinical application for diagnosis of Mycobacterium tuberculosis infection in China, but it lacked a head-to-head economic evaluation based on the Chinese population. This study aimed to estimate the cost-utility and the cost-effectiveness of both EC and tuberculin pure protein derivative (TB-PPD) for diagnosis of Mycobacterium tu…
Exploring the knowledge, attitudes, behaviors and training needs of obstetric and gynecological nurses regarding Covid-19 during the peak period of the pandemic in middle-risk areas of China
Coordinating technological progress and environmental regulation in CO2 mitigation
No prominent works on this page.
Coordinating technological progress and environmental regulation in CO2 mitigation
Recombinant mycobacterium tuberculosis fusion protein for diagnosis of mycobacterium tuberculosis infection
Objectives: Recombinant Mycobacterium tuberculosis fusion protein (EC) was anticipated to be used for the scale-up of clinical application for diagnosis of Mycobacterium tuberculosis infection in China, but it lacked a head-to-head economic evaluation based on the Chinese population. This study aimed to estimate the cost-utility and the cost-effectiveness of both EC and tuberculin pure protein derivative (TB-PPD) for diagnosis of Mycobacterium tu…
Exploring the knowledge, attitudes, behaviors and training needs of obstetric and gynecological nurses regarding Covid-19 during the peak period of the pandemic in middle-risk areas of China
Walking, the body, and the pandemic
In December 2022, the dynamic zero-COVID control policy came to an end, marking the conclusion of a three-year pandemic that affected 1.4 billion Chinese people. The pandemic and related policies created a unique, temporary, and historic social ecosystem where walking became more crucial than ever before. The pandemic not only severely restricted people's movement in public spaces but also exposed the longstanding contradictions between human bod…
Medicine (3 works) · China (2 works) · Economics (2 works) · Environmental health (2 works) · Pandemic (2 works) · 2019-20 coronavirus outbreak (1 work) · Art Therapy and Mental Health (1 work) · Climate change mitigation (1 work) · Climate Change Policy and Economics (1 work) · Coronavirus disease 2019 (COVID-19 (1 work)